Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Under the Spotlight: Agentic AI
In an interview with Pharmaceutical Outsourcing, ArisGlobal’s Jason Bryant discusses the premise of AI’s next high-profile incarnation, the technology’s potential in late-stage pharma R&D operations, emerging early use cases, and some of the guardrails that need to be in place to ensure trusted, impactful use. read more
Flexibility as a Core IND Strategy
With the increasing complexities of current IND programs, it is critical to work with regulatory agencies to seek input early in the process. read more
Rethinking the Architecture of Adverse Event Processing
Deploying AI agents to handle data collection, coding, medical review, and quality-checking makes signal management autonomous at the processing stage. read more
Leveraging AI and ML to Optimize Drug Discovery – a CRO Perspective
CROs supporting early-stage drug discovery projects are establishing their own internal AI platforms to address their clients’ needs in an evolving field. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Bora, Onconic Ink Manufacturing Deal for U.S. JAQBO Clinical Program
Thursday, July 23, 2026
Bora Pharmaceuticals and Onconic Therapeutics have signed a manufacturing agreement to support the U.S. clinical development of JAQBO tablets, a ... read more
ImmuPharma Selects Thermo Fisher Scientific Drug Product CDMO for Kapiglucagon Program
Wednesday, July 22, 2026
The selection of Thermo Fisher represents an important Chemistry, Manufacturing and Controls (“CMC”) milestone for the Kapiglucagon program and is ... read more
Restore Vision and Forge Biologics Announce AAV Development and cGMP Manufac-turing Partnership
Wednesday, July 22, 2026
Restore Vision and Forge Biologics, a manufacturer of gene therapies and member of Ajinomoto Bio-Pharma Services, announced a development and ... read more
Wheeler Bio Appoints Chief Development Officer
Wednesday, July 22, 2026
Wheeler Bio announced the appointment of Rajesh Beri, Ph.D., as Chief Development Officer. read more
Phanes, Merck Expand Trial Pact to Test CD47 Bispecific with KEYTRUDA in 1L Biliary Tract Cancer
Tuesday, July 21, 2026
Phanes Therapeutics has expanded its clinical trial collaboration and supply agreement with Merck to evaluate spevatamig in combination with KEYTRUDA ... read more